{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:21:18Z","timestamp":1792419678115,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99754-7","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T23:50:37Z","timestamp":1755647437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Shweta","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhad","family":"Kural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan Gopal","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"99754_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","volume":"9","author":"CE Condrat","year":"2020","unstructured":"Condrat, C. E. et al. miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9, 276 (2020).","journal-title":"Cells"},{"key":"99754_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1662","volume":"12","author":"LF Sempere","year":"2021","unstructured":"Sempere, L. F., Azmi, A. S. & Moore, A. microRNA-based diagnostic and therapeutic applications in cancer medicine. WIREs RNA 12, e1662 (2021).","journal-title":"WIREs RNA"},{"key":"99754_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms23031226","volume":"23","author":"K Khamina","year":"2022","unstructured":"Khamina, K. et al. A microRNA next-generation-sequencing discovery assay (miND) for genome-scale analysis and absolute quantitation of circulating microRNA biomarkers. Int. J. Mol. Sci. 23, 1226 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"99754_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/andr.13258","volume":"11","author":"V Const\u00e2ncio","year":"2023","unstructured":"Const\u00e2ncio, V., Tavares, N. T., Henrique, R., Jer\u00f3nimo, C. & Lobo, J. MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?. Andrology 11, 651\u2013667 (2023).","journal-title":"Andrology"},{"key":"99754_CR5","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3390\/diagnostics13193072","volume":"13","author":"JP Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz, J. P., P\u00e9rez-Moreno, P., P\u00e9rez, Y. & Calaf, G. M. The role of MicroRNAs in breast cancer and the challenges of their clinical application. Diagnostics 13, 3072 (2023).","journal-title":"Diagnostics"},{"key":"99754_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard, C. C., Cheng, H. H. & Tewari, M. MicroRNA profiling: Approaches and considerations. Nat. Rev. Genet. 13, 358\u2013369 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"99754_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5455\/aim.2021.29.266-269","volume":"29","author":"KP Seputra","year":"2021","unstructured":"Seputra, K. P., Purnomo, B. B., Susianti, H., Kalim, H. & Purnomo, A. F. miRNA-21 serum evaluation in BPH, hormone sensitive prostate cancer, and castrate resistant prostate cancer: Attempt for diagnostic biomarker evaluation. Acta Inform. Med. 29, 266 (2021).","journal-title":"Acta Inform. Med."},{"key":"99754_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1245\/s10434-012-2600-3","volume":"20","author":"C Li","year":"2013","unstructured":"Li, C. et al. MiRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann. Surg. Oncol. 20, 397\u2013405 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"99754_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40246-019-0220-8","volume":"13","author":"M Chen","year":"2019","unstructured":"Chen, M. & Zhao, H. Next-generation sequencing in liquid biopsy: Cancer screening and early detection. Hum. Genom. 13, 34 (2019).","journal-title":"Hum. Genom."},{"key":"99754_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K. & Algeciras-Schimnich, A. Analysis of circulating microRNA: Preanalytical and analytical challenges. Clin. Chem. 57, 833\u2013840 (2011).","journal-title":"Clin. Chem."},{"key":"99754_CR11","doi-asserted-by":"publisher","first-page":"18774","DOI":"10.1038\/s41598-024-66770-y","volume":"14","author":"AK Pathak","year":"2024","unstructured":"Pathak, A. K. et al. Development of a robust and generalizable algorithm \u201cgQuant\u201d for accurate normalizer gene selection in qRT-PCR analysis. Sci. Rep. 14, 18774 (2024).","journal-title":"Sci. Rep."},{"key":"99754_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"99754_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.beth.2020.05.002","volume":"51","author":"T Jiang","year":"2020","unstructured":"Jiang, T., Gradus, J. L. & Rosellini, A. J. Supervised machine learning: A brief primer. Behav. Ther. 51, 675\u2013687 (2020).","journal-title":"Behav. Ther."},{"key":"99754_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","volume":"47","author":"SJ Rigatti","year":"2017","unstructured":"Rigatti, S. J. Random forest. J. Insur. Med. N. Y. 47, 31\u201339 (2017).","journal-title":"J. Insur. Med. N. Y."},{"key":"99754_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107739","volume":"49","author":"PS Reel","year":"2021","unstructured":"Reel, P. S., Reel, S., Pearson, E., Trucco, E. & Jefferson, E. Using machine learning approaches for multi-omics data analysis: A review. Biotechnol. Adv. 49, 107739 (2021).","journal-title":"Biotechnol. Adv."},{"key":"99754_CR16","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.3390\/s23063080","volume":"23","author":"E Bostanci","year":"2023","unstructured":"Bostanci, E. et al. Machine learning analysis of RNA-seq data for diagnostic and prognostic prediction of colon cancer. Sensors 23, 3080 (2023).","journal-title":"Sensors"},{"key":"99754_CR17","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/bjc.2016.151","volume":"114","author":"E Sharova","year":"2016","unstructured":"Sharova, E. et al. A circulating miRNA assay as a first-line test for prostate cancer screening. Br. J. Cancer 114, 1362\u20131366 (2016).","journal-title":"Br. J. Cancer"},{"key":"99754_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.21873\/cgp.20336","volume":"19","author":"D Pawelka","year":"2022","unstructured":"Pawelka, D. et al. Machine-learning-based analysis identifies miRNA expression profile for diagnosis and prediction of colorectal cancer: A preliminary study. Cancer Genom. Proteom. 19, 503\u2013511 (2022).","journal-title":"Cancer Genom. Proteom."},{"key":"99754_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","volume":"21","author":"SP Balk","year":"2003","unstructured":"Balk, S. P., Ko, Y.-J. & Bubley, G. J. Biology of prostate-specific antigen. J. Clin. Oncol. 21, 383\u2013391 (2003).","journal-title":"J. Clin. Oncol."},{"key":"99754_CR20","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.2147\/CMAR.S250829","volume":"12","author":"CJ McNally","year":"2020","unstructured":"McNally, C. J., Ruddock, M. W., Moore, T. & McKenna, D. J. Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer: A literature review. Cancer Manag. Res. 12, 5225\u20135241 (2020).","journal-title":"Cancer Manag. Res."},{"key":"99754_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","volume":"35","author":"JC Nickel","year":"2008","unstructured":"Nickel, J. C. Inflammation and benign prostatic hyperplasia. Urol. Clin. N. Am. 35, 109\u2013115 (2008).","journal-title":"Urol. Clin. N. Am."},{"key":"99754_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/medicina56020094","volume":"56","author":"VC Munteanu","year":"2020","unstructured":"Munteanu, V. C. et al. MiRNA-based inspired approach in diagnosis of prostate cancer. Medicina (Mex.) 56, 94 (2020).","journal-title":"Medicina (Mex.)"},{"key":"99754_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","volume":"70","author":"L Fabris","year":"2016","unstructured":"Fabris, L. et al. The potential of microRNAs as prostate cancer biomarkers. Eur. Urol. 70, 312\u2013322 (2016).","journal-title":"Eur. Urol."},{"key":"99754_CR24","doi-asserted-by":"publisher","first-page":"1065757","DOI":"10.3389\/fgene.2023.1065757","volume":"14","author":"G Jain","year":"2023","unstructured":"Jain, G. et al. Urinary extracellular vesicles miRNA\u2014A new era of prostate cancer biomarkers. Front. Genet. 14, 1065757 (2023).","journal-title":"Front. Genet."},{"key":"99754_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13277-011-0154-9","volume":"32","author":"F Yaman Agaoglu","year":"2011","unstructured":"Yaman Agaoglu, F. et al. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 32, 583\u2013588 (2011).","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"99754_CR26","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/genes13122320","volume":"13","author":"SM Jokovi\u0107","year":"2022","unstructured":"Jokovi\u0107, S. M. et al. MiR-375 and miR-21 as potential biomarkers of prostate cancer: Comparison of matching samples of plasma and exosomes. Genes 13, 2320 (2022).","journal-title":"Genes"},{"key":"99754_CR27","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-018-1938-2","volume":"50","author":"P Porzycki","year":"2018","unstructured":"Porzycki, P., Ciszkowicz, E., Semik, M. & Tyrka, M. Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition. Int. Urol. Nephrol. 50, 1619\u20131626 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"99754_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/diagnostics10010038","volume":"10","author":"MY Konoshenko","year":"2020","unstructured":"Konoshenko, M. Y. et al. The panel of 12 cell-free microRNAs as potential biomarkers in prostate neoplasms. Diagnostics 10, 38 (2020).","journal-title":"Diagnostics"},{"key":"99754_CR29","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.3390\/ijms21165667","volume":"21","author":"E Ciszkowicz","year":"2020","unstructured":"Ciszkowicz, E., Porzycki, P., Semik, M., Kaznowska, E. & Tyrka, M. MiR-93\/miR-375: Diagnostic potential, aggressiveness correlation and common target genes in prostate cancer. Int. J. Mol. Sci. 21, 5667 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"99754_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-019-1923-2","volume":"17","author":"W Wen","year":"2019","unstructured":"Wen, W. et al. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. J. Transl. Med. 17, 186 (2019).","journal-title":"J. Transl. Med."},{"key":"99754_CR31","first-page":"D148","volume":"48","author":"H-Y Huang","year":"2020","unstructured":"Huang, H.-Y. et al. miRTarBase 2020: Updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 48, D148\u2013D154 (2020).","journal-title":"Nucleic Acids Res."},{"key":"99754_CR32","doi-asserted-by":"publisher","first-page":"D154","DOI":"10.1093\/nar\/gkm952","volume":"36","author":"S Griffiths-Jones","year":"2008","unstructured":"Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: Tools for microRNA genomics. Nucleic Acids Res. 36, D154-158 (2008).","journal-title":"Nucleic Acids Res."},{"key":"99754_CR33","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"99754_CR34","first-page":"20","volume":"2010","author":"M Safran","year":"2010","unstructured":"Safran, M. et al. GeneCards Version 3: The human gene integrator. Database J. Biol. Databases Curation 2010, 20 (2010).","journal-title":"Database J. Biol. Databases Curation"},{"key":"99754_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/cancers15010261","volume":"15","author":"B Lumbreras","year":"2022","unstructured":"Lumbreras, B. et al. Variables associated with false-positive PSA results: A cohort study with real-world data. Cancers 15, 261 (2022).","journal-title":"Cancers"},{"key":"99754_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/jina.jina_5_17","volume":"4","author":"L Kumar","year":"2017","unstructured":"Kumar, L., Kumar, S. & Agarwal, S. To find the role of DNA damage marker 8-hydroxy 2-deoxy guanosine in patients of prostate cancer, benign prostatic hyperplasia and its association to other prognostic factors of prostate cancer. J. Integr. Nephrol. Androl. 4, 55\u201355 (2017).","journal-title":"J. Integr. Nephrol. Androl."},{"key":"99754_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-016-0523-5","volume":"15","author":"E Endzeli\u0146\u0161","year":"2016","unstructured":"Endzeli\u0146\u0161, E. et al. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: A systematic review. Mol. Cancer 15, 41 (2016).","journal-title":"Mol. Cancer"},{"key":"99754_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"99754_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-017-0645-7","volume":"36","author":"S Huang","year":"2017","unstructured":"Huang, S. et al. Downregulation of miR-141-3p promotes bone metastasis via activating NF-\u03baB signaling in prostate cancer. J. Exp. Clin. Cancer Res. 36, 173 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"99754_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12885-025-13444-1","volume":"25","author":"D Li","year":"2025","unstructured":"Li, D. et al. Elevated miR-221-3p inhibits epithelial\u2013mesenchymal transition and biochemical recurrence of prostate cancer via targeting KPNA2: An evidence-based and knowledge-guided strategy. BMC Cancer 25, 34 (2025).","journal-title":"BMC Cancer"},{"key":"99754_CR41","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/0008-5472.CAN-09-1448","volume":"69","author":"J Ribas","year":"2009","unstructured":"Ribas, J. et al. miR-21: An androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res. 69, 7165\u20137169 (2009).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99754-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:54:38Z","timestamp":1757408078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99754-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99754-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30477"}}